CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
(0.0% 1d)
(-34.4% 1m)
(-49.5% 1y)
(0.0% 2d)
(0.0% 3d)
(-4.2% 7d)
(-67.58%
volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 203,631,973
Sec
Filling
|
Patents
| 26 employees
compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. novel scientific insights are validated and explored deeply inside our labs before compass pursues the best proprietary combinations of therapeutics into human clinical trials. in 2015, compass quietly closed a $120mm series a financing to fund our ambitious plan to build a fully-integrated biopharmaceutical company from the ground up. our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value only by delivering therapeutics with meaningful efficacy beyond
add to watch list
Paper trade
email alert is off
Press-releases
Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors
Published: 2024-04-16
(Crawled : 12:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -4.23%
| O: 2.93%
H: 3.8%
C: -0.63%
ctx-8371
first
tumors
therapeutics
study
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
Published: 2024-04-12
(Crawled : 12:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -11.98%
| O: -4.19%
H: 9.38%
C: 1.25%
conference
therapeutics
foundation
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
Published: 2024-04-10
(Crawled : 12:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -15.27%
| O: -8.93%
H: 12.03%
C: 1.27%
therapeutics
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-09
(Crawled : 16:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -13.53%
| O: 2.06%
H: 0.0%
C: 0.0%
association
tumors
cancer
research
for
meeting
therapeutics
negative
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
Published: 2024-03-21
(Crawled : 13:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -30.66%
| O: 2.83%
H: 3.21%
C: 2.75%
update
therapeutics
financial
results
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-02-29
(Crawled : 13:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -15.52%
| O: 5.17%
H: 1.09%
C: -2.73%
conference
biopharma
global
therapeutics
Compass Therapeutics Provides Corporate Update
Published: 2024-01-05
(Crawled : 13:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -5.16%
| O: 0.0%
H: 10.0%
C: 5.16%
update
therapeutics
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-09
(Crawled : 12:30)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -14.53%
| O: 2.33%
H: 0.57%
C: -8.52%
update
therapeutics
financial
results
Compass Therapeutics to Participate in Upcoming Investor Events
Published: 2023-11-07
(Crawled : 13:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -16.48%
| O: 0.0%
H: 1.14%
C: 0.0%
therapeutics
Compass Therapeutics to Participate in Upcoming Investor Events
Published: 2023-08-30
(Crawled : 12:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
| -39.75%
| O: -3.28%
H: 9.01%
C: 2.97%
therapeutics
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001171843-24-001275
4
2024-03-11
2024-03-08
Buy
A
40000
40000
0001171843-24-000715
4
2024-02-09
2024-02-08
Sell
F
49198
3124426
0001171843-24-000714
4
2024-02-09
2024-02-08
Sell
F
44782
6570566